Table 1. Tungstate targets identified by proteomics in different hypothalamic nuclei.
Spota | Uniprot | Protein | Phenotypeb | Ratioc | P | Nuclei |
Axonal growth and neuronal plasticity | ||||||
213 | O08553 | CRMP2 | L | 1.61 | 0.011 | ARC |
215 | O08553 | CRMP2 | L | 1.34 | 0.012 | ARC |
244 | O08553 | CRMP2 | L | −1.19 | 0.031 | ARC |
297 | P46660 | Alpha-internexin | L | −1.8 | 0.024 | ARC |
62 | P08553 | NEFM | O | 1.5 | 0.037 | ARC |
1475 | P03995 | GFAP | O | 1.21 | 0.017 | ARC |
242 | O08553 | CRMP2 | L | 1.34 | 0.021 | PVN |
278 | P46660 | Alpha-internexin | O | −1.1 | 0.022 | PVN |
217 | O08553 | CRMP2 | L | −1.32 | 0.061 | LHA |
219 | O08553 | CRMP2 | L | −1.41 | 0.029 | LHA |
224 | O08553 | CRMP2 | L | −1.61 | 0.006 | LHA |
176 | O08553 | CRMP2 | O | 1.19 | 0.059 | LHA |
Cytoskeleton and neuronal structure | ||||||
1475 | P60710 | Beta-actin | O | 1.21 | 0.017 | ARC |
1559 | P60710 | Beta-actin | O | 1.63 | 0.028 | ARC |
1058 | Q8BXF8 | Actin-relatedprotein M1 | O | −1.21 | 0.047 | ARC |
1224 | P68369 | Alpha-tubulin,chain 1A | O | 1.61 | 0.013 | ARC |
636 | A2AQ07 | Tubulin beta1 | L | −1.81 | 0.038 | LHA |
Energy metabolism | ||||||
415 | P14152 | Malate dehydrogenase | L | −1.21 | 0.044 | ARC |
479 | P14152 | Malate dehydrogenase | L | 1.2 | 0.027 | ARC |
1419 | P17182 | Enolase 1 | L | 1.36 | 0.04 | ARC |
1224 | Q8BKZ9 | Pyruvate dehydrogenase | O | 1.61 | 0.013 | ARC |
277 | Q9DCT2 | NADH dehydrogenase | L | 1.72 | 0.015 | PVN |
329 | Q9DCT2 | NADH dehydrogenase | L | 1.32 | 0.02 | PVN |
303 | P17751 | Triosephosphate isomerase | O | −1.82 | 0.023 | PVN |
567 | Q811J3 | Aconitase 2 | O | −1.77 | 0.034 | PVN |
359 | Q00623 | Apolipoprotein A-I | O | −1.6 | 0.002 | PVN |
431 | Q04447 | Creatine kinase B | L | 1.14 | 0.003 | ARC |
361 | P21550 | Enolase 3 | L | −1.21 | 0.028 | LHA |
373 | P17182 | Enolase 1 | L | −1.62 | 0.05 | LHA |
518 | P14152 | Malate dehydrogenase | L | −1.21 | 0.023 | LHA |
664 | Q9D051 | Pyruvate dehydrogenase-β | L | −1,42 | 0,049 | LHA |
230 | P52480 | Pyruvate kinase | O | 1.43 | 0.015 | LHA |
1475 | Q04447 | Creatine kinase B | O | 1.21 | 0.017 | ARC |
648 | P35486 | Pyruvate dehydrogenase-α | O | 1.61 | 0.059 | LHA |
Others | ||||||
98 | P48722 | Hspa 4L | L | 1.19 | 0.021 | ARC |
1604 | Q9Z2Q6 | Septin-5 | L | 1.33 | 0.036 | ARC |
1224 | P62814 | Vacuolar H+ATPase B2 | O | 1.61 | 0.013 | ARC |
1058 | P31938 | MEK1 | O | −1.21 | 0.047 | ARC |
141 | P50518 | V- ATPase E1 | L | −1.17 | 0.046 | PVN |
242 | P50516 | V-ATPase A | L | 1.34 | 0.021 | PVN |
329 | P70202 | Latexin | L | 1.32 | 0.02 | PVN |
428 | Q9R0Y5 | Adenilate kinase 1 | O | −1.77 | 0.009 | PVN |
559 | P09671 | Superoxide dismutase | O | −1.21 | 0.047 | PVN |
149 | P63017 | Hspa8 | L | −1.51 | 0.052 | LHA |
664 | P62880 | Gnb 2 | L | −1.42 | 0.049 | LHA |
Spot numbers corresponding to 2D images for each type of nuclei (Figure 2).
Mice phenotypes: L = lean. O = obese.
Ratios of protein expression levels calculated using DeCyder software as the fold change in normalized spot volume comparing tungstate treated and non treated animals (Student’s t test based on the log of the ratio of the treated group to the control group).